Global Market Reach Octapharma operates in 120 countries with a diverse therapeutic portfolio across Immunotherapy, Haematology, and Critical Care, presenting extensive opportunities for expanding plasma and protein-based treatments in both emerging and established markets.

Innovative R&D Capabilities With seven dedicated R&D sites and ongoing development of innovative human proteins from plasma and cell lines, there is a strong potential for partnering on new biotherapeutics and personalized medicine solutions.

Digital and Engagement Leadership Award-winning digital communication and employee engagement strategies demonstrate a strong corporate reputation and a forward-thinking approach, which can facilitate trust and collaboration with potential suppliers and partners.

Manufacturing Scalability Operating five state-of-the-art manufacturing facilities in Europe and a widespread plasma donation network with over 195 centers, Octapharma offers scalable manufacturing and supply chain solutions suited for rapid expansion or new product launches.

Financial Stability and Growth Generating revenues between one and ten billion dollars, Octapharma's robust financial position provides a solid foundation for strategic investments and long-term collaborations in plasma-derived therapeutics and innovative biotech products.